Maria Koehler M.D., Ph.D.
Net Worth

Last updated:

What is Maria Koehler M.D., Ph.D. net worth?

The estimated net worth of Dr. Maria Koehler M.D., Ph.D. is at least $2,862,540 as of 1 Apr 2024. He owns shares worth $351,742 as insider, has earned $10,718 from insider trading and has received compensation worth at least $2,500,080 in Repare Therapeutics Inc..

What is the salary of Maria Koehler M.D., Ph.D.?

Dr. Maria Koehler M.D., Ph.D. salary is $625,020 per year as Executive Vice President & Chief Medical Officer in Repare Therapeutics Inc..

How old is Maria Koehler M.D., Ph.D.?

Dr. Maria Koehler M.D., Ph.D. is 68 years old, born in 1957.

What stocks does Maria Koehler M.D., Ph.D. currently own?

As insider, Dr. Maria Koehler M.D., Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Repare Therapeutics Inc. (RPTX) Executive Vice President & Chief Medical Officer 231,409 $1.52 $351,742

What does Repare Therapeutics Inc. do?

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.

RPTX logo
RPTX
Repare Therapeutics Inc.
$1.52

Maria Koehler M.D., Ph.D. insider trading

Repare Therapeutics Inc.

Dr. Maria Koehler M.D., Ph.D. has made 5 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 300 units of RPTX stock worth $1,398 on 1 Apr 2024.

The largest trade he's ever made was exercising 115,000 units of RPTX stock on 18 Jan 2022. As of 1 Apr 2024 he still owns at least 231,409 units of RPTX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Shares 300 $4.66 $1,398
Sale
Common Shares 500 $4.64 $2,320
Sale
Common Shares 500 $4.62 $2,310
Sale
Common Shares 500 $4.6 $2,300
Sale
Common Shares 500 $4.78 $2,390
Option
Employee Stock Option (right to buy) 20,190 $2.06 $41,632
Option
Employee Stock Option (right to buy) 23,556 $2.43 $57,123
Option
Common Shares 20,190 $2.06 $41,632
Option
Common Shares 23,556 $2.43 $57,123
Option
Employee Stock Option (right to buy) 51 $2.43 $124
Option
Employee Stock Option (right to buy) 48,456 $2.06 $99,916
Option
Common Shares 48,456 $2.06 $99,916
Option
Common Shares 51 $2.43 $124
Option
Employee Stock Option (right to buy) 115,000 $15.63 $1,797,450
Option
Common Shares 48,511 $2.24 $108,859
Option
Employee Stock Option (right to buy) 48,511 $2.24 $108,859

Repare Therapeutics key executives

Repare Therapeutics Inc. executives and other stock owners filed with the SEC: